about
Regular long-term red blood cell transfusions for managing chronic chest complications in sickle cell diseaseBlood transfusion for preventing primary and secondary stroke in people with sickle cell diseaseRegular long-term red blood cell transfusions for managing chronic chest complications in sickle cell diseaseRegular long-term red blood cell transfusions for managing chronic chest complications in sickle cell diseaseGenetic risk factors for cerebrovascular disease in children with sickle cell disease: design of a case-control association study and genomewide screenRegular long-term red blood cell transfusions for managing chronic chest complications in sickle cell diseaseA biopsychosocial model for the management of patients with sickle-cell disease transitioning to adult medical careProteomic and biomarker studies and neurological complications of pediatric sickle cell diseaseImplementation of a Process for Initial Transcranial Doppler Ultrasonography in Children With Sickle Cell Anemia.How I manage cerebral vasculopathy in children with sickle cell disease.Silent Cerebral Infarct Transfusion (SIT) trial imaging core: application of novel imaging information technology for rapid and central review of MRI of the brain.Can STOP Trial Velocity Criteria Be Applied to Iranian Children with Sickle Cell Disease?Intra-individual variation in blood flow velocities in cerebral arteries of children with sickle cell diseaseLessons from the Stroke Prevention Trial in Sickle Cell Anemia (STOP) study.Blood transfusion for preventing stroke in people with sickle cell disease.Erythrocytapheresis: Do Not Forget a Useful Therapy!Parental problem-solving abilities and the association of sickle cell disease complications with health-related quality of life for school-age children.Association between ischemic stroke and iron-deficiency anemia: a population-based study.Mean Platelet Volume can Predict Cerebrovascular Events in Patients with Sickle Cell Anemia.Managing sickle cell disease.Prevalence of stroke in children admitted with sickle cell anaemia to Mulago Hospital.Blood transfusion for preventing primary and secondary stroke in people with sickle cell disease.Cerebral hemodynamic assessment and neuroimaging across the lifespan in sickle cell disease.Interventions for preventing silent cerebral infarcts in people with sickle cell disease.Genetic mapping and exome sequencing identify 2 mutations associated with stroke protection in pediatric patients with sickle cell anemia.Non-invasive imaging of oxygen extraction fraction in adults with sickle cell anaemiaMaintaining High Level of Care at Satellite Sickle Cell Clinics.Cerebral blood flow velocity and language functioning in pediatric sickle cell disease.Current concepts in the management of stroke in children with sickle cell disease.Problems with implementing a standardised transcranial Doppler screening programme: impact of instrumentation variation on STOP classification.Transcranial Doppler ultrasound in neurovascular diseases: diagnostic and therapeutic aspects.Health of adults living with a clinically significant haemoglobinopathy in New South Wales, Australia.Factors influencing the decline in stroke mortality: a statement from the American Heart Association/American Stroke Association.Emerging point-of-care technologies for sickle cell disease screening and monitoring.Transcranial doppler re-screening of subjects who participated in STOP and STOP II.Reticulocyte count is the most important predictor of acute cerebral ischemia and high-risk transcranial Doppler in a newborn cohort of 395 children with sickle cell anemia.Prophylactic RhCE and Kell antigen matching: impact on alloimmunization in transfusion-dependent patients with myelodysplastic syndromes.Comparison of automated erythrocytapheresis versus manual exchange transfusion to treat cerebral macrovasculopathy in sickle cell anemia.Silent cerebral infarcts in very young children with sickle cell anaemia are associated with a higher risk of stroke.Erythrocyte-exchange with the OPTIA™ cell separator in patients with sickle-cell disease.
P2860
Q24201184-B57B0AD3-0307-46BF-9ED6-BBA1E381AE30Q24202463-32769205-0FAA-409E-9C5D-EBB38A535DD0Q24234406-770651D5-93A2-45B2-9E23-EE384136BA67Q24240205-A9821141-E972-42D0-9A86-D0E322B295CDQ24793784-45853BFA-F4B2-4991-8CE6-768A6CB3A211Q26471968-63B73B32-B91E-4C2A-A401-715AA44C23DEQ27024148-79C5EFF6-B3B6-4198-BA8D-9AB297A1437FQ27027066-F5BDB564-2B5E-4C5D-A9D7-4146BCF9CF1AQ27334023-D150610A-1982-4B18-8C20-C892D45D7102Q30945117-D5E9AE77-E31A-4902-A0BC-2B5EFFEB610CQ31152018-2CB59387-9166-429F-9E3F-D19C4AFA70BDQ33765890-5A600FFE-0203-4F57-A077-93A82B0B3AE1Q33841486-D3147F78-D7DF-4E7F-B5AB-29EF7AAB0D2EQ33929537-E5FC309C-6092-4CCE-A6D5-28A9F96DB704Q34546913-C6D2118C-FBAD-4645-8125-3DA71AEACBBDQ34870383-D5BEBDA9-719D-447B-88D5-1409C2215869Q35039900-77624C1C-F67B-4BD4-837F-00ACF821B53FQ35070656-90163075-635B-4BC5-A231-5FC8AC1B57EEQ35277610-2047C3C9-AAB1-485D-904C-9A750923EC3FQ35582684-0AA5B278-FE59-438F-97EB-5A0B984CB9BFQ36136500-6751BF6E-9258-4B31-AA67-F65137EE5FECQ36251052-F26B7331-190F-4EB9-9A34-AB2B360E8B6BQ36349336-262C5082-00B8-4A2C-9FB8-0DBADB57B64CQ36370980-07C2D36D-DF87-4EAC-A643-FA44F91C53BAQ36779445-4756F501-42B1-4CF9-8DFA-131F592E6A48Q37238159-5DC1A6AA-2336-4AEF-9D52-B59940FDC7E7Q37607927-D107C2B5-88EC-465C-860A-17554E6DDF31Q37686573-38C3C6CB-BC78-40AA-B870-881290F365C8Q37831815-064810C0-6139-4976-8420-F800156F18E3Q37946316-AE86042A-2ACB-40D0-B9AF-D71B40D2AB40Q38050822-12B5B364-1EEB-4CF3-B4CE-8FD531E9C59AQ38120022-0D9256F2-A256-4D63-B67C-6F403E1B2E89Q38169038-11866A3A-CCB8-43C0-8AC0-86BAAE8E41B3Q38804432-D841B3EA-DAE1-4CA5-A5AB-6B45906BC989Q38953349-7E7DBBC5-BB60-443A-824E-E832D4F058EEQ39494212-317A47EB-6A32-4372-8AFB-E9CA02F1E490Q40376149-7615EBBD-87E4-49B5-BBCF-79E3F766A6B9Q40829777-07B16217-A1A4-46CD-A70D-784C334B46FFQ41683705-771817D6-670E-4BC8-AF64-E6611493A91DQ41967433-4B58EDE0-A631-4123-9D04-C91F14A6EA8D
P2860
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
1998年论文
@zh
1998年论文
@zh-cn
name
Stroke prevention trial in sickle cell anemia.
@en
type
label
Stroke prevention trial in sickle cell anemia.
@en
prefLabel
Stroke prevention trial in sickle cell anemia.
@en
P2093
P1476
Stroke prevention trial in sickle cell anemia
@en
P2093
C Driscoll
D Brambilla
D Gallagher
P304
P356
10.1016/S0197-2456(97)00099-8
P407
P50
P577
1998-02-01T00:00:00Z